130 related articles for article (PubMed ID: 16470634)
1. Enantiomeric screening of racemic citalopram and metabolites in human urine by entangled polymer solution capillary electrophoresis: an innovatory robustness/ruggedness study.
Berzas-Nevado JJ; Villaseñor-Llerena MJ; Guiberteau-Cabanillas C; Rodríguez-Robledo V
Electrophoresis; 2006 Feb; 27(4):905-17. PubMed ID: 16470634
[TBL] [Abstract][Full Text] [Related]
2. Screening of citalopram, fluoxetine and their metabolites in human urine samples by gas chromatography-mass spectrometry. A global robustness/ruggedness study.
Berzas Nevado JJ; Villaseñor Llerena MJ; Guiberteau Cabanillas C; Rodríguez Robledo V
J Chromatogr A; 2006 Aug; 1123(1):130-3. PubMed ID: 16814307
[TBL] [Abstract][Full Text] [Related]
3. Stereoselective biotransformation of the selective serotonin reuptake inhibitor citalopram and its demethylated metabolites by monoamine oxidases in human liver.
Rochat B; Kosel M; Boss G; Testa B; Gillet M; Baumann P
Biochem Pharmacol; 1998 Jul; 56(1):15-23. PubMed ID: 9698084
[TBL] [Abstract][Full Text] [Related]
4. Enantiomeric determination, validation and robustness studies of racemic citalopram in pharmaceutical formulations by capillary electrophoresis.
Berzas Nevado JJ; Guiberteau Cabanillas C; Villaseñor Llerena MJ; Rodríguez Robledo V
J Chromatogr A; 2005 Apr; 1072(2):249-57. PubMed ID: 15887495
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic and pharmacodynamic responses to chronic administration of the selective serotonin reuptake inhibitor citalopram in rats.
Wikell C; Apelqvist G; Carlsson B; Hjorth S; Bergqvist PB; Kugelberg FC; Ahlner J; Bengtsson F
Clin Neuropharmacol; 1999; 22(6):327-36. PubMed ID: 10626092
[TBL] [Abstract][Full Text] [Related]
6. Analytical procedures for the determination of the selective serotonin reuptake inhibitor antidepressant citalopram and its metabolites.
Unceta N; Goicolea MA; Barrio RJ
Biomed Chromatogr; 2011 Jan; 25(1-2):238-57. PubMed ID: 21058412
[TBL] [Abstract][Full Text] [Related]
7. Stereoselective single-dose kinetics of citalopram and its metabolites in rats.
Kugelberg FC; Carlsson B; Ahlner J; Bengtsson F
Chirality; 2003 Aug; 15(7):622-9. PubMed ID: 12840828
[TBL] [Abstract][Full Text] [Related]
8. Enantiomeric separation of citalopram and its metabolites by capillary electrophoresis.
Mandrioli R; Fanali S; Pucci V; Raggi MA
Electrophoresis; 2003 Aug; 24(15):2608-16. PubMed ID: 12900873
[TBL] [Abstract][Full Text] [Related]
9. Stereospecific determination of citalopram and desmethylcitalopram by capillary electrophoresis and liquid-phase microextraction.
Andersen S; Halvorsen TG; Pedersen-Bjergaard S; Rasmussen KE; Tanum L; Refsum H
J Pharm Biomed Anal; 2003 Sep; 33(2):263-73. PubMed ID: 12972091
[TBL] [Abstract][Full Text] [Related]
10. Analytical methodologies for the enantiodetermination of citalopram and its metabolites.
Budău M; Hancu G; Rusu A; Muntean DL
Chirality; 2020 Jan; 32(1):32-41. PubMed ID: 31702071
[TBL] [Abstract][Full Text] [Related]
11. Micellar electrokinetic chromatographic method for the determination of letrozole, citalopram and their metabolites in human urine.
Rodríguez Flores J; Salcedo AM; Llerena MJ; Fernández LM
J Chromatogr A; 2008 Mar; 1185(2):281-90. PubMed ID: 18280488
[TBL] [Abstract][Full Text] [Related]
12. Early-phase postmortem redistribution of the enantiomers of citalopram and its demethylated metabolites in rats.
Kugelberg FC; Kingbäck M; Carlsson B; Druid H
J Anal Toxicol; 2005; 29(4):223-8. PubMed ID: 15975250
[TBL] [Abstract][Full Text] [Related]
13. Enantioseparation of citalopram enantiomers by capillary electrophoresis: Method development through experimental design and computational modeling.
Budău M; Hancu G; Muntean DL; Papp LA; Cârje AG; Garaj V
Chirality; 2020 Aug; 32(8):1119-1128. PubMed ID: 32506601
[TBL] [Abstract][Full Text] [Related]
14. Determination of the enantiomers of citalopram, its demethylated and propionic acid metabolites in human plasma by chiral HPLC.
Rochat B; Amey M; Van Gelderen H; Testa B; Baumann P
Chirality; 1995; 7(6):389-95. PubMed ID: 7577348
[TBL] [Abstract][Full Text] [Related]
15. Postmortem redistribution of the enantiomers of citalopram and its metabolites: an experimental study in rats.
Kugelberg FC; Druid H; Carlsson B; Ahlner J; Bengtsson F
J Anal Toxicol; 2004; 28(8):631-7. PubMed ID: 15538956
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic consequences of a citalopram treatment discontinuation.
Voirol P; Rubin C; Bryois C; Kosel M; Buclin T; Baumann P
Ther Drug Monit; 1999 Jun; 21(3):263-6. PubMed ID: 10365634
[TBL] [Abstract][Full Text] [Related]
17. Pressure-assisted electrokinetic injection stacking for citalopram drug to achieve highly sensitive detection and enantioseparation by capillary electrophoresis.
Xu Z; Ye F; Wang Y; Li A
Se Pu; 2015 Sep; 33(9):988-94. PubMed ID: 26753288
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the enantiomers of citalopram and its demethylated metabolites using chiral liquid chromatography.
Kosel M; Eap CB; Amey M; Baumann P
J Chromatogr B Biomed Sci Appl; 1998 Nov; 719(1-2):234-8. PubMed ID: 9869386
[TBL] [Abstract][Full Text] [Related]
19. Serum concentrations of citalopram--dose-dependent variation in R- and S-enantiomer ratios.
Tanum L; Strand LP; Refsum H
Pharmacopsychiatry; 2010 Jul; 43(5):190-3. PubMed ID: 20503148
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic drug monitoring of racemic citalopram: a 5-year experience in Sweden, 1992-1997.
Reis M; Lundmark J; Bengtsson F
Ther Drug Monit; 2003 Apr; 25(2):183-91. PubMed ID: 12657912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
